Pharmena revenue drops

Listed on the alternative, small-cap market, pharmaceutical, Pharmena, had PLN 1.74 million net profit in 2016, a drop from PLN 2.7 million in 2015. Revenue from sales amounted to PLN 17 million (PLN 18.4 million in 2015), the company said in its financial report. “The decrease stems, from lower sales in Q1. One of the…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It